KIT and gastrointestinal stromal tumor: Similarly, arterial‐ and venous‐phase CECT radiomics can robustly predict KIT exon 9 mutation in gastrointestinal stromal tumors (GIST), underscoring the generalizability of combined multiphase imaging [318].